Astellas Gene Therapies

Astellas Gene Therapies is an independent company operating in the heart of San Francisco, California. The company currently employs 398 individuals and generates approximately $100 million in annual revenue. Astellas Gene Therapies specializes in the development of genetic medicines aimed at providing groundbreaking treatments for patients. Their research focuses on three key gene therapy modalities: gene replacement, exon skipping gene therapy, and vectorized RNA knockdown. The company leverages its innovative scientific approach and advanced in-house manufacturing capabilities to advance these programs towards clinical trials. What sets Astellas Gene Therapies apart is its commitment to developing transformative gene therapies. The company boasts industry-leading internal manufacturing expertise, ensuring a high level of control and quality in the development process. For more information about Astellas Gene Therapies and their groundbreaking work, please visit their website at astellasgenetherapies.com.